Malaria vaccine research & innovation: the intersection of IA2030 and zero malaria
- PMID: 33298967
- PMCID: PMC7677906
- DOI: 10.1038/s41541-020-00259-3
Malaria vaccine research & innovation: the intersection of IA2030 and zero malaria
Conflict of interest statement
DCK is an employee of PATH (a not-for-profit organization), has no financial interest in any for-profit organization, and declares no competing interests. PATH is funded to innovate and partner in developing and implementing malaria vaccines and other interventions to control and eliminate malaria.
References
-
- RBM. Zero Malaria Starts with Me (RBM & UNOPS, Geneva, 2018); https://zeromalaria.africa/wp-content/uploads/2018/06/Agenda-setting-EN-....
-
- RBM. RBM Partnership to End Malaria Annual Report 2019 (RBM & UNOPS, Geneva, 2020); https://endmalaria.org/sites/default/files/RBM%20Annual%20Report%202019.pdf.
-
- WHO. Immunization Agenda 2030: A Global Strategy to Leave No One Behind (WHO, Geneva, 2020); http://www.who.int/immunization/immunization_agenda_2030/en/. - PubMed
-
- WHO. World malaria report 2019 (WHO, Geneva, 2019); https://www.who.int/publications-detail-redirect/9789241565721.
-
- WHO. Seventy-third World Health Assembly WHA73(9) Agenda item 11.3: Immunization Agenda 2030 (WHO, Geneva, 2020); https://apps.who.int/gb/ebwha/pdf_files/WHA73/A73(9)-en.pdf.
Publication types
LinkOut - more resources
Full Text Sources
